Question Title

* 1. Did your facility receive written notification from Anthem on the change to AIM in advance of the program implementation?

Question Title

* 2. Have you received notice that Anthem-AIM will be taking over authorization for Commercial Products requiring all new authorizations on July 1st, 2019?

Question Title

* 3. Did your office participate in a training session before the go live date?

Question Title

* 4. Are you currently experiencing problems using the web portal to complete an authorization?

Question Title

* 5. On average, how long are the current phone wait times?

Question Title

* 6. Is your support staff able to enter the authorization data without PT assistance? (I.e. could the requested information be completed without the skills of the PT to interpret and enter the appropriate data?)

Question Title

* 7. How long does it take on average for administrative and clinical staff combined to complete one initial or follow up authorization?

Question Title

* 8. How many visits are typically authorized in the INITIAL authorization period?

Question Title

* 9. How frequently were the requested visits granted on the INITIAL authorization?

Question Title

* 10. Is the date range on the initial authorization reasonable?

Question Title

* 11. How many visits are typically authorized in the SECOND authorization period?

Question Title

* 12. How frequently were the requested visits granted on the SECOND authorization?

Question Title

* 13. Is the date range on the second authorization reasonable?

Question Title

* 14. On average, how long does it take to get a response to an authorization request?

Question Title

* 15. Are there differences in the number of authorized visits between patients with orthopedic conditions and those patients with nonorthopedic or complex conditions?

Question Title

* 16. Are appropriate clinical data and outcome measures considered during the authorization approval process?

Question Title

* 17. Is the frequency of requested functional tool measures consistent with best practice?

Question Title

* 18. What is your perceived assessment of the AIM program’s adverse impact on patient outcomes?

Question Title

* 19. In what areas are your patients adversely affected? Check all that apply:

Question Title

* 20. What mode of authorization transmisson do you use most often?

Question Title

* 21. Given a choice, what is your preferred mode of authorization transmission?

Question Title

* 22. Are you experiencing claims payment issues related to the AIM program?

Question Title

* 23. Have you contacted AIM or Anthem for additional assistance?

Question Title

* 25. Additional Comments

0 of 25 answered
 

T